← Leaderboards
Richard Dwayne Williams
University Of Iowa
$255,089
Attributed
$255,089
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $126.7K · FY2005–07$200K$150K$100K$50K$0
'05
'06
'07
Funding mix
By agency
NIH$255,089 · 3
By mechanism
R21$249,637 · 1
M01$5,452 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Iowa
Same institution · by research overlap
- George J Weiner$29,916,936
- Karl J Kreder$6,492,300
- Timothy L Ratliff$20,384,281
- John F Engelhardt$56,184,900
- Dawn E Quelle$8,297,216
Others in their field
Top investigators on “Novel Therapeutics”
- David Heimbrook · Leidos Biomedical Research, Inc.$355,066,875
- Judith S. Currier · University Of California Los Angeles$321,442,024
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Leonard Freedman · Leidos Biomedical Research, Inc.$263,124,404
- Daniel R Kuritzkes · Brigham And Women'S Hospital$246,024,897
- Sharon A Nachman · Johns Hopkins University$212,395,175
Research focus
Novel TherapeuticsProstatic NeoplasmsLocalizedNeoplastic CellProstateProstate Cancer TherapyCollagenLigandsMalignant Neoplasm Of ProstateMediatingOperative Surgical ProceduresCessation Of LifeFutureApoptoticGene DeliveryGene Delivery SystemBaseGene TransferCytotoxicImmuneImmunityApoptosisEffectivenessProteins
Grant awards (4)
TNF-related apoptosis-inducing ligan (TRAIL) gene therapy for prostate cancer$122,982
R21 · FY2007 · CA · contact PI
AD5-TRAIL IN MEN WITH CLINICALLY ORGAN CONFINED PROSTATE CANCER$3,121
M01 · FY2007 · RR · contact PI
Ad5-TRIAL gene therapy for prostate cancer$126,655
R21 · FY2006 · CA · contact PI
ROLE OF INTRAVENOUS ERYTHROMYCIN IN POST-OPERATIVE ILEUS$2,331
M01 · FY2005 · RR